Table 1 Clinical and histopathological criteria of the study cohort
Parameter | Frequency (N = 368) | Percent (%) |
|---|---|---|
Age, median (range) | 48 (21–72) | |
Menopausal status | ||
Premenopausal | 206 | 60 |
Postmenopausal | 157 | 40 |
Clinical T stage | ||
T1 | 19 | 8.68 |
T2 | 74 | 33.8 |
T3 | 56 | 25.6 |
T4 | 70 | 32 |
Tx | 48 | 13 |
Unknown | 101 | 27.4 |
Clinical N stage | ||
N0 | 36 | 20 |
N1 | 88 | 49 |
N2 | 35 | 19.4 |
N3 | 21 | 11.7 |
Nx | 15 | 4.7 |
Unknown | 173 | 47 |
Histopathology of cores | ||
IDC | 329 | 89.4 |
ILC | 16 | 4.4 |
Unknown | 23 | 6.2 |
Lymphovascular invasion | ||
Present | 45 | 12.2 |
Absent | 79 | 21.5 |
Unknown | 244 | 66.3 |
Grade | ||
1 | 0 | 0 |
2 | 227 | 88.7 |
3 | 28 | 11.3 |
Unknown | 112 | 30.4 |
Subtypes | ||
HR+/Her2− | 164 | 53.8 |
HR+/Her2+ | 46 | 15.1 |
Her2-enriched | 45 | 15.1 |
TNBC | 50 | 16.4 |
Unknown | 63 | 17.1 |